Shares cratered as Nuburu Inc. disclosed that NYSE American had issued a formal warning over the company's failure to timely release material information, adding existential regulatory risk to a stock already deep in penny-stock territory. Nuburu's NYSE Warning Fires a Starting Gun on Delisting Risk — Can a Defense Acquisition Outrun the Clock?
Shares of Nuburu Inc. (BURU) plunged 12.2% to $0.49 on massive volume after NYSE American issued a formal warning that strikes at the company's credibility with investors at the worst possible time. On October 19, 2026, Nuburu received a warning letter from NYSE Regulation regarding a failure to timely disclose material information related to events on September 30, 2026.
The exchange warned that future violations that would otherwise warrant a warning under Section 1009 will instead result in immediate suspension and commencement of delisting proceedings.
• The Disclosure Failure That Triggered the Warning. The letter centers on Nuburu's delayed disclosure of material agreements tied to its July 2026 public offering and a debt restructuring involving Brick Lane Capital Management — specifically, a side agreement with Esousa Group Holdings and a share-return deal to cancel a $15 million promissory note were disclosed only on October 6, days after the events occurred on September 30. That six-day lag violated rules demanding immediate public disclosure of significant corporate developments. For a sub-dollar stock already trading with a ".BC" noncompliance tag, this kind of lapse tells the market that management's internal controls are not keeping pace with its deal-making.
• The Compliance Deadline Is Nine Days Away. If Nuburu is not in compliance with continued listing standards by October 29, 2026, NYSE American may initiate delisting proceedings.
As of June 30, total stockholders' equity was $9.4 million , above the $4 million threshold — but the exchange's patience is visibly wearing thin. A delisting would exile shares to over-the-counter markets, crushing liquidity and institutional access.
• Tekne Brings Real Revenue but Hasn't Stopped the Bleeding. Nuburu completed its acquisition of a 70% controlling interest in Tekne S.p.A. , an Italian defense-industrial firm with approximately 185 personnel across three Italian sites and roughly $93.1 million in program value.
Nuburu paid a fixed price of €5.2 million, with €1.2 million at signing and €4 million deferred through March 2027. Yet the stock has fallen from $1.01 to $0.49 in a week — investors are pricing governance risk above operational upside.
• Volume Tells the Story of Investor Panic. Prior-session volume hit 7.68 million shares — more than 5× the 65-day average of 1.36 million. Insiders have been net buyers over the past 12 months, acquiring $1.5 million worth of shares with no insider selling reported , but that signal is drowned out by a market now questioning whether this stock will still be listed by November. The Tekne deal gives Nuburu a credible defense platform; the disclosure failure gives NYSE regulators a reason to pull the plug.